...man könnte ja argumentieren was hat ACB vom US Gesetzesentwurf ..ich denke so wie die Strategie flächendeckend angesetzt ist, ist die Pipline für weitere Partnerschaften gegeben!
Depends on what ACB's US strategy is and its relationship to Australis Capital (AUSAF).
Australis Capital Mentioned During ACB Earnings Call 9/12/19
9/12/19
seekingalpha.com/article/...nings-call-transcript?part=single
Quote:
Terry Booth
You wouldn't think that our M&A activity has slowed if you sat in my chair and the amount of work that we're doing with the amount of opportunities that we have in the United States. We started out in the United States with their little brother and (Australis?) Capital which we have some back in rates. Their trade on CSC USA they've done nine deals themselves, smaller deals, but they've set a - set a footprint and actually really teed up some good people to help us with different regulatory issues in the various provinces.
We've got a significant MSO review tour of the States, I think that's common knowledge out there in the markets. And we are laser focused on CBD derived from hemp and the various opportunities that exist in that. When USA passed the Farm Act they leapfrogged across the rest of the world or over the rest of the world in CBD derived from hemp.
Some call it CBD frenzy, but I don't believe it is because we know that it works and having it rescheduled in the U.S. is a tremendous boon to the CBD industry and our strategic partners and Australis Capital [ph] are helping us talk to some of the top companies in the world with respect to that in itself. And there is a couple more hurdles with the CBD industry including the FDA ruling on injectables and we have a good idea on how that's going to go. But to say that we slowed our M&A activity, we've not closed a bunch recently, but there is a - I'm very busy in that regard, probably 90% of my time is dealt on new opportunities.
Zurück
